Interesting ImagesFDG PET/CT in a Patient With Mantle Cell Lymphoma and COVID-19 Typical FindingsPlaye, Margot MD∗; Siavellis, Justine MD†; Braun, Thorsten PhD†; Soussan, Michaël PhD∗,‡Author Information From the Departments of ∗Nuclear Medicine †Hematology, Avicenne Hospital, Hopitaux universitaires Paris Seine Saint Denis, AP-HP, France ‡UMR 1288, Laboratoire d'Imagerie Translationnelle en Oncologie (LITO), Inserm, Institut Curie, France. Received for publication April 8, 2020; revision accepted April 9, 2020. Conflicts of interest and sources of funding: none declared. Correspondence to: Playe Margot, MD, Department of Nuclear Medicine, Hôpital Avicenne, Assistance Publique Hôpitaux de Paris, University Paris XIII, 125 rue de Stalingrad, 93009 Bobigny, France. E-mail: email@example.com. Clinical Nuclear Medicine: July 2020 - Volume 45 - Issue 7 - p e305-e306 doi: 10.1097/RLU.0000000000003113 Buy Metrics Abstract A 52-year-old woman with no medical history was admitted on March 18, 2020, presenting since 3 days asthenia, abdominal pain, and dry cough but no fever. Adenomegalies, splenomegaly, leukocytosis, and elevated LDH suggested mature lymphoproliferation. Considering the current health context, an RT-PCR testing for COVID-19 (coronavirus disease 2019) was performed and found to be positive. Early chest CT showed no sign of pulmonary infection but multiple adenomegalies. An 18F-FDG PET/CT performed 5 days later to assess the extent of the hemopathy revealed the apparition of FDG-avid bilateral ground glass and subpleural curvilinear opacities suggesting COVID-19–associated pneumopathy. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.